Manufacturing Living Therapies
Enabling “next-generation” drugs through automation and standardization This article was first published on Charles River Laboratories Eureka Blog. Please support our partners at Charles River. Cell and gene therapy continues to drive biopharmaceutical investment and pipelines, despite COVID-related research and clinical trial disruptions. Last year, the global cell therapy market size was $7.8 billion, expanding annually […]
Towards standardizing flow cytometry sample preparation protocols without centrifugation
Now WatchingWebinar: Towards standardizing flow cytometry sample preparation protocols without centrifugation We sponsored the May 13, 2021 installment of the flowcytometryUK society webinar, hosted by renowned flow cytometrist Derek Davies, Ph.D. of the Francis Crick Institute. Curiox Applications Scientist Noma Ngwenya and Charles River Laboratories Principal Scientist III and Flow Cytometry Core Director Christoph Eberle, Ph.D. discussed how Laminar Wash™ technology supports sample prep for flow cytometry […]
Next-Generation Technology for Suspension Cell Preparation
Novel instrumentation enables gentle and consistent cell washing for researchers across the life sciences. This article was first published on Charles River Laboratories Eureka Blog. Please support our partners at Charles River. “The future is now” certainly rings true for biotechnology and medicine. Gene sequencing and editing have become routine, cell biology is understood enough […]
Curiox Laminar Wash Featured on Charles River Lab’s Eureka Science Blog
Collaboration with Charles River Laboratories expands Pharmaceutical and biotech companies, contract research organizations, and academics worldwide have discovered that Laminar Wash™ technology can improve their cellular analysis data quality and sample preparation workflows. Among Curiox’s customers is Charles River Laboratories (CRL), the world leader in addressing the challenges of pharmaceutical development. An early adopter of […]
How to wash away barriers to therapeutic cancer vaccine development
Developing neoantigen-based cancer vaccines necessitates comprehensive cellular characterization for iterative therapeutic improvement, which Laminar Wash™ systems may facilitate at multiple steps. Vaccines are probably the second-most effective advancement in the annals of human medicine, after sanitation. Most of us recognize the value of vaccines in infectious disease. Yet, swept under the rug amongst the COVID-19 global pandemic is another form of immune-boosting injection combating a terrible […]